To evaluate the long-term safety of pregabalin in refractory partial epilepsy.

Inclusion Criteria:

• Must have met the inclusion criteria for preceding double-blind study.
• Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion Criteria:

• Pregnant or considering becoming pregnant.
• Receiving any concomitant medication that could alter the effectiveness of their medication response or seizure frequency.